# Salivary Epidermal Growth Factor (EGF) Concentration Before and After Treatment of Reflux Laryngitis

> **NCT01389401** · — · COMPLETED · sponsor: **Faculdade de Ciências Médicas da Santa Casa de São Paulo** · enrollment: 36 (actual)

## Conditions studied

- Gastroesophageal Reflux Disease (GERD)
- Chronic Laryngitis

## Interventions

- **DRUG:** omeprazole

## Key facts

- **NCT ID:** NCT01389401
- **Lead sponsor:** Faculdade de Ciências Médicas da Santa Casa de São Paulo
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2011-01
- **Final completion:** 2011-07
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2013-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01389401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01389401, "Salivary Epidermal Growth Factor (EGF) Concentration Before and After Treatment of Reflux Laryngitis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01389401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*